Alemtuzumab as first- and second-line treatment in patients with Sézary Syndrome - the experience of a tertiary center.
Miguel NogueiraCatarina LauMaria Dos Anjos TeixeiraRita PeixeiroRenata CabralIolanda FernandesPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)